Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 409 of 1,261

  1. US 10723803

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  2. US 10724007

    Development of dengue virus vaccine components

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  3. US 10722523

    Chemoimmunotherapy for epithelial cancer

    The Regents of the University of California · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  4. US 10722594

    Pyrrolobenzodiazepine-anti-CD22 antibody conjugates

    ADC THERAPEUTICS SA · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  5. US 10722475

    Stealth nanocapsules for protein delivery

    The Regents of the University of California · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  6. US 10722478

    Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine

    TONIX PHARMA LIMITED · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  7. US 10722499

    Anyhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  8. US 10723702

    Photocrosslinking reagents and methods of use thereof

    Northwestern University · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  9. US 10723857

    Polyimide aerogels with reduced shrinkage from isothermal aging

    United States of America as represented by the Administrator of NASA · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  10. US 10723784

    Compositions and methods for preparing a subject for organ or non-organ implantation

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  11. US 10723787

    Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  12. US 10723785

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  13. US 10723780

    Synthetic somatostatin receptor ligands

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  14. US 10723759

    Inhibitors of glucocorticoid receptor

    ORIC PHARMACEUTICALS, INC. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  15. US 10723741

    DNA polymerase IIIC inhibitors and use thereof

    Acurx Pharmaceuticals, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  16. US 10723733

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  17. US 10723778

    Variants of adrenomedullin and calcitonin gene-related peptide and methods of use

    The Board of Regents of the University of Oklahoma · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  18. US 10724026

    Engineered primate L-methioninase for therapeutic purposes

    The Board of Regents of the University of Texas System · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  19. US 10723737

    Compositions and methods for treating neurodegenerative diseases and cardiomyopathy

    The Regents of the University of California · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  20. US 10722561

    Aquaporin 2 protects cattle from ticks and tick-borne parasites

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  21. US 10722583

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  22. US 10722581

    Phonophoretic cannabidiol composition and transdermal delivery system

    Essential Green Goodness LLC · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  23. US 10722579

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  24. US 10722573

    Compositions for stimulation of mammalian innate immune resistance to pathogens

    The Board of Regents of the University of Texas System · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.